Search

Author/Creator Rong, Dawei

1. Cancer-associated fibroblast exosomes promote chemoresistance to cisplatin in hepatocellular carcinoma through circZFR targeting signal transducers and activators of transcription (STAT3)/ nuclear factor -kappa B (NF-κB) pathway. Issue 3 (1st March 2022)

Authors:
Zhou, Yun; Tang, Weiwei; Zhuo, Han; Zhu, Deming; Rong, Dawei; Sun, Jin; Song, Jinhua
Journal:
Bioengineered
Issue:
Volume 13:Issue 3(2022)
Page Start:
4786
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Clinical significance of CD8+ T cell immunoreceptor with Ig and ITIM domains+ in locally advanced gastric cancer treated with SOX regimen after D2 gastrectomy. (3rd June 2019)

Authors:
Tang, Weiwei; Pan, Xiongxiong; Han, Di; Rong, Dawei; Zhang, Minghui; Yang, Lulu; Ying, Jie; Guan, Hua; Chen, Ziyi; Wang, Xuehao
Journal:
Oncoimmunology
Issue:
Volume 8:Number 6(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. GLIS1 intervention enhances anti-PD1 therapy for hepatocellular carcinoma by targeting SGK1-STAT3-PD1 pathway. Issue 2 (14th February 2023)

Authors:
Rong, Dawei; Wang, Yuliang; Liu, Li; Cao, Hengsong; Huang, Tian; Liu, Hanyuan; Hao, Xiaopei; Sun, Guangshun; Sun, Guoqiang; Zheng, Zhiying; Kang, Junwei; Xia, Yongxiang; Chen, Ziyi; Tang, Weiwei; Wang, Xuehao
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 11:Issue 2(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Macrophage GSK3β-deficiency inhibits the progression of hepatocellular carcinoma and enhances the sensitivity of anti-PD1 immunotherapy. Issue 12 (20th December 2022)

Authors:
Sun, Guangshun; Liu, Hanyuan; Zhao, Jie; Zhang, Jinyu; Huang, Tian; Sun, Guoqiang; Zhao, Siqi; Zhang, Zihao; Cao, Hengsong; Rong, Dawei; Kong, Xiangyi; Ji, Qinghua; Liu, Li; Wang, Xuehao; Tang, Weiwei; Xia, Yongxiang
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 12(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Morbidity, Prognostic Factors, and Competing Risk Nomogram for Combined Hepatocellular-Cholangiocarcinoma. (10th December 2021)

Authors:
Chen, Xiaoyuan; Lu, Yiwei; Shi, Xiaoli; Chen, Xuejiao; Rong, Dawei; Han, Guoyong; Zhang, Long; Ni, Chuangye; Zhao, Jie; Gao, Yun; Wang, Xuehao
Other Names:
Granito Alessandro Academic Editor.
Journal:
Journal of oncology
Issue:
Volume 2021(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗